Rhinomed Ltd
ASX:RNO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alkindo Naratama Tbk PT
IDX:ALDO
|
ID |
|
STV Group PLC
LSE:STVG
|
UK |
|
S
|
Saputo Inc
OTC:SAPIF
|
CA |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| AU |
|
Rhinomed Ltd
ASX:RNO
|
11.4m AUD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
854.1B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.5B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.7B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD |
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.5B GBP |
Loading...
|
Market Distribution
| Min | -6 907 100% |
| 30th Percentile | 21.6% |
| Median | 38.3% |
| 70th Percentile | 58.2% |
| Max | 2 095.9% |
Other Profitability Ratios
Rhinomed Ltd
Glance View
Rhinomed Ltd. is medical technology company, which engages in the identification, acquisition, and commercialization of stage therapeutic delivery technologies. The company is headquartered in Richmond, Victoria. The company went IPO on 2007-09-21. The Company’s products include Mute, Turbine, Pronto Sleep, and Pronto Clear. The Mute is a nasal technology that is designed to allow the user to manage the sleep by breathing more and snoring less. The Turbine is a nasal dilator designed to assist the user to breathe during aerobic exercise. Pronto Sleep, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the soothing vapors of four pure essential oils. Pronto Clear, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the ability to deliver the vapors of six pure essential oils traditionally known to clear a stuffy nose naturally. Its products, including Turbine and Mute, are sold online and through pharmacies, sleep clinics, and sports stores.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Rhinomed Ltd is 74.8%, which is in line with its 3-year median of 74.8%.
Over the last 3 years, Rhinomed Ltd’s Gross Margin has increased from 59.5% to 74.8%. During this period, it reached a low of 59.5% on Jun 30, 2020 and a high of 74.8% on Jun 30, 2023.
